Abstract: An information processing apparatus (2000) detects a battery cell in which an abnormality (for example, leakage) occurs among a plurality of battery cells connected in series. A first differential voltage acquisition unit (2020) acquires a first differential voltage for each of the plurality of battery cells. The first differential voltage of the battery cell is a difference between a voltage of the battery cell after charging is completed and a voltage of the battery cell at a time when an operation is performed for a predetermined time after charging is completed. A determination unit (2040) determining that an abnormality occurs in a first battery cell, in a case where a difference between the first differential voltage of the first battery cell and the first differential voltage of a battery cell having a next largest first differential voltage of the first battery cell, is greater than or equal to a first predetermined value.

Abstract: A method for bonding separators (3) having a multilayer structure that comprises a substrate layer (3a) and a ceramic layer (3b), the ceramic layer (3b) being laminated on at least one surface of the substrate layer (3a) and having higher heat resistance properties than the substrate layer (3a), the method comprising steps of: applying an adhesive member (10) onto the ceramic layer (3b) and then peeling off the adhesive member (10) to remove a portion of the ceramic layer (3b) together with the adhesive member (10); and heating a portion of the separator (3), from which the ceramic layer (3b) has been removed, to heat-weld the separator (3) to other separator (3).

Abstract: An information processing apparatus (2000) detects a battery cell in which an abnormality (for example, leakage) occurs among a plurality of battery cells connected in series. A first differential voltage acquisition unit (2020) acquires a first differential voltage for each of the plurality of battery cells. The first differential voltage of the battery cell is a difference between a voltage of the battery cell after charging is completed and a voltage of the battery cell at a time when an operation is performed for a predetermined time after charging is completed. A determination unit (2040) determining that an abnormality occurs in a first battery cell, in a case where a difference between the first differential voltage of the first battery cell and the first differential voltage of a battery cell having a next largest first differential voltage of the first battery cell, is greater than or equal to a first predetermined value.

Abstract: A method for manufacturing an electrochemical device in which an electrode assembly in which two types of electrodes are superposed on each other with a separator 4 interposed therebetween, is housed in an outer container, the two types of electrodes each including an active material-applied portion where an active material layer is formed on a current collector, and an active material-non-applied portion where an active material layer is not formed on the current collector, the method including joining an electrode terminal and stack of the active material-non-applied portions, with respect to each type of electrodes; pressing a connection portion between the electrode terminal and the stack of the active material-non-applied portions after said joining step; and housing the electrode assembly in the outer container made of a flexible film after pressing.

Abstract: An iron oxide particle constituting a Resovist (trademark) absorbs a small quantity of light in a near infrared region and emits a weak photoacoustic signal. According to a particle having a catechol-like compound and iron atoms, the particle having a ratio of the number of moles of the catechol-like compound to the number of moles of the iron atoms of 270/10,000 or more, light absorption in the near infrared region increases and a strong photoacoustic signal can be transmitted.

Abstract: Provided is a particle which can stably hold a dye in itself even in an aqueous solution such as serum, in order to solve such a problem of a particle containing ICG, which has been conventionally used in a contrast agent or the like, that the ICG is a dye having a hydrophilic functional group and hence the ICG leaks out of the particle in an aqueous solution such as serum. More specifically, provided is a particle including a hydrophobic dye having a cyanine structure, in which the hydrophobic dye is represented by the following chemical formula (1).

Abstract: Provided is a particle having a large photoacoustic signal per unit dye, the particle including: one of a hydrophobic metal naphthalocyanine dye and a hydrophobic metal phthalocyanine dye; one of an oil, a fatty acid, and a fatty acid ester as a matrix material; and a surfactant, in which a ratio of the weight of the matrix material to the weight of the particle is 50% or more.

Abstract: To provide a particle promoting hydrophobic metal phthalocyanine aggregation, having absorption in a wavelength region suitable for a photoacoustic imaging method and having a high molar absorbance coefficient per particle by increasing the weight percentage of the dye in the particle. The particle of the present invention is a particle having a hydrophobic metal phthalocyanine and a surfactant, wherein the weight percentage of the hydrophobic metal phthalocyanine is 6% or more.

Abstract: A conventional silicon naphthalocyanine-containing liposome is required to incorporate a dye dispersed therein for use in photodynamic therapy, and is thus low in dye content and also low in photoacoustic signal. According to a lipid particle containing a silicon naphthalocyanine analog, in which the ratio A/B of an absorption coefficient A at a first absorption local maximum to an absorption coefficient B at a second absorption local maximum in a range from 700 nm to 800 nm is 5.0 or less, the dye content in the lipid particle can be increased and the photoacoustic signal intensity can be improved.

Abstract: It is intended to provide a novel contrast agent for photoacoustic imaging that is highly capable of binding to a target molecule and generates high photoacoustic signals. The present invention provides a contrast agent for photoacoustic imaging represented by Formula 1: MNP-((L)l-(P)m)n??(Formula 1) (wherein MNP represents a particle containing an iron oxide particle; L represents a linker molecule; P represents a ligand molecule; l represents 0 or 1; and m and n represent an integer of 1 or larger), the contrast agent for photoacoustic imaging including: a particle containing an iron oxide particle that absorbs light in a near-infrared region; and at least one or more ligand molecule(s) immobilized on the particle containing an iron oxide particle, wherein the immobilization density of the ligand molecule is equal to or higher than the cell surface density of a target molecule.

Abstract: An iron oxide particle constituting a Resovist (trademark) absorbs a small quantity of light in a near infrared region and emits a weak photoacoustic signal. According to a particle having a catechol-like compound and iron atoms, the particle having a ratio of the number of moles of the catechol-like compound to the number of moles of the iron atoms of 270/10,000 or more, light absorption in the near infrared region increases and a strong photoacoustic signal can be transmitted.

Abstract: Indocyanine green-containing particles each include a metal oxide particle or a metal particle and an aggregate of indocyanine green. The aggregate of indocyanine green has a relative maximum absorbance at 880 nm or more and 910 nm or less.

Abstract: A compound including a polymer is represented by general formula (1): L-Y-A??(1) wherein, A is a single-chain antibody moiety, which is a polypeptide including an antigen-binding site, L is a linker moiety, which is a polypeptide including a protease cleavage site, Y is a peptide moiety, which includes 0 or more amino acids connecting the linker moiety L with the single-chain antibody moiety A, and the linker moiety L binds to an N terminus of the peptide moiety Y or an N terminus of the single-chain antibody moiety A.

Abstract: An object of the present invention is to increase the dye content in nanoparticles and to improve the signal intensity per particle.

Abstract: A compound including a polymer is represented by general formula (1): L-Y-A??(1) wherein, A is a single-chain antibody moiety, which is a polypeptide including an antigen-binding site, L is a linker moiety, which is a polypeptide including a protease cleavage site, Y is a peptide moiety, which includes 0 or more amino acids connecting the linker moiety L with the single-chain antibody moiety A, and the linker moiety L binds to an N terminus of the peptide moiety Y or an N terminus of the single-chain antibody moiety A.

Abstract: It is intended to provide a novel contrast agent for photoacoustic imaging that is highly capable of binding to a target molecule and generates high photoacoustic signals. The present invention provides a contrast agent for photoacoustic imaging represented by Formula 1: MNP?((L)l?(P)m)n ??(Formula 1) (wherein MNP represents a particle containing an iron oxide particle; L represents a linker molecule; P represents a ligand molecule; l represents 0 or 1; and m and n represent an integer of 1 or larger), the contrast agent for photoacoustic imaging including: a particle containing an iron oxide particle that absorbs light in a near-infrared region; and at least one or more ligand molecule(s) immobilized on the particle containing an iron oxide particle, wherein the immobilization density of the ligand molecule is equal to or higher than the cell surface density of a target molecule.

Abstract: It is intended to provide a novel contrast agent for photoacoustic imaging that is highly capable of binding to a target molecule and generates high photoacoustic signals. The present invention provides a contrast agent for photoacoustic imaging represented by Formula 1: MNP-((L)l-(P)m)n??(Formula 1) (wherein MNP represents a particle containing an iron oxide particle; L represents a linker molecule; P represents a ligand molecule; l represents 0 or 1; and m and n represent an integer of 1 or larger), the contrast agent for photoacoustic imaging including: a particle containing an iron oxide particle that absorbs light in a near-infrared region; and at least one or more ligand molecule(s) immobilized on the particle containing an iron oxide particle, wherein the immobilization density of the ligand molecule is equal to or higher than the cell surface density of a target molecule.

Abstract: There is provided a graft polymer-containing substrate that reduces nonspecific adsorption of impurities onto a substrate surface and specifically captures a target substance. There is provided a graft polymer-containing substrate with a graft polymer formed on the surface thereof, characterized in that the graft polymer includes monomer units represented by the following general formulas (1) and (2): wherein R1, R2, and R3 represent one of a hydrogen atom and a methyl group, R4 represents a group including any of a carboxyl group, a succinimide group, an aldehyde group, an epoxy group, a bromo group, an amino group, and a maleimide group, X represents a hydrophilic crosslinking spacer having 15 or more atoms, and l, m, and n are an integer of 1 or greater.

Abstract: When an antigen present at lesion sites is detected using a compound containing a single-chain antibody moiety, the single-chain antibody moiety binds to the antigen present at sites other than lesion sites. As a result, the detection of the lesion sites with high sensitivity and high contrast is difficult, and a compound solving this problem is demanded. The present invention provides a compound including a polymer represented by general formula (1): L-Y-A??(1) wherein, A is a single-chain antibody moiety, which is a polypeptide including an antigen-binding site; L is a linker moiety, which is a polypeptide including a protease cleavage site; Y is a peptide moiety, which including 0 or more amino acids connecting the linker moiety L with the single-chain antibody moiety A; and the linker moiety L binds to an N terminus of the peptide moiety Y or an N terminus of the single-chain antibody moeity A.

Abstract: The invention provides a structural member having an excellent ability to prevent the nonspecific adsorption of a biomolecule and a labeling substance to the surface of a substrate, and a method of producing the structural member. The structural member includes a substrate and a polymer present on a surface of the substrate, in which the polymer is formed from a polymer of a multi-vinyl monomer represented by the following general formula (I) or (II), and has a crosslinked structure: where R, R?, and R? are independently a hydrogen atom or a methyl group, and X represents a hydrophilic functional group in which fifteen or more atoms are linked in series.